|
SN-NJ-R147
N/A |
|
Composite hydrogel containing irinotecan nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R148
N/A |
|
Indocyanine green and liquid fluorocarbon dual-mode contrast nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R149
N/A |
|
R8 modified nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R150
N/A |
|
Baicalein-loaded PLGA nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R151
N/A |
|
Astaxanthin nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R152
N/A |
|
Phospholipid nanoparticle composite hydrogel with core-shell structure
|
￥Member visible
|
|
|
SN-NJ-R153
N/A |
|
RGD modified nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R154
N/A |
|
Nanoparticle composite hydrogel loaded with basic fibroblast growth factor
|
￥Member visible
|
|
|
SN-NJ-R155
N/A |
|
Rifabutin nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R156
N/A |
|
PEI modified PLGA nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R157
N/A |
|
Thymopentapeptide nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R158
N/A |
|
Palifampicin Nanoparticle Composite Hydrogel
|
￥Member visible
|
|
|
SN-NJ-R159
N/A |
|
Rapamycin nanoparticle composite hydrogel capable of inhibiting vascular smooth muscle cells
|
￥Member visible
|
|
|
N-NJ-R160
N/A |
|
Coumarin-6 nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R162
N/A |
|
Mannose modified chitosan nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R161
N/A |
|
Matrine loaded nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R162
N/A |
|
Mannose modified chitosan nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R163
N/A |
|
Antifungal itraconazole nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R164
N/A |
|
DNA/RNA/plasmid nanoparticle controlled release hydrogel
|
￥Member visible
|
|
|
SN-NJ-R165
N/A |
|
Cyclovastatin PLGA nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R166
N/A |
|
Methotrexate-loaded PLGA nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R167
N/A |
|
Gene-carrying cationic PLGA nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R168
N/A |
|
Neurotoxin-loaded PLGA nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R169
N/A |
|
Composite hydrogel containing doxorubicin chondroitin sulfate nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R170
N/A |
|
PLGA-PEG nanoparticle composite hydrogel loaded with cisplatin
|
￥Member visible
|
|
|
SN-NJ-R171
N/A |
|
Temozolomide nanoparticle composite hydrogel
|
￥Member visible
|
|
|
SN-NJ-R172
N/A |
|
Ropivacaine PLGA Nanoparticle Composite Hydrogel
|
￥Member visible
|
|
|
SN-NJ-R173
N/A |
|
Hepatitis B vaccine nanoparticle composite hydrogel coated with protamine
|
￥Member visible
|
|
|
SN-NJ-R174
N/A |
|
Composite hydrogel containing ICG nanoparticles
|
￥Member visible
|
|
|
SN-NJ-R175
N/A |
|
Folic acid-loaded capecitabine nanospheres
|
￥Member visible
|
|
|
SN-NJ-R176
N/A |
|
PLGA nanoparticle composite hydrogel containing doxorubicin and siRNA
|
￥Member visible
|
|
|
SN-NJ-R177
N/A |
|
PLGA/chitosan drug-loaded nanoparticle composite hydrogel
|
￥Member visible
|
